HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast.

Abstract
Three cases of cutaneous angiosarcoma of the breast that arose in irradiated skin tissue in women who had previously undergone treatment for breast carcinoma are reported. A review of the literature identified 55 cases of cutaneous angiosarcoma following radiation therapy as part of the treatment of carcinoma of the breast. For all 58 assembled cases, the mean age at the time of adjuvant radiation therapy for breast carcinoma was 64 years (range 42-83). The mean time to subsequent diagnosis in irradiated skin was 75 months (range 12-192). The estimated 3-year overall survival for all 58 patients was only 20%, similar to that of patients with the general form of angiosarcoma. Postirradiation angiosarcoma of the breast has a variety of presentations; thus diagnosis is often delayed. Early diagnosis relies on a high index of suspicion and appropriate histopathologic studies, as the clinical and histopathologic findings may be confused with other conditions. Treatment should be aggressive and include local surgery with consideration of adjuvant systemic chemotherapy.
AuthorsJaggi Rao, Joel G Dekoven, J David Beatty, Glenn Jones
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 49 Issue 3 Pg. 532-8 (Sep 2003) ISSN: 0190-9622 [Print] United States
PMID12963926 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Breast Neoplasms (pathology, radiotherapy, surgery)
  • Carcinoma, Intraductal, Noninfiltrating (pathology, radiotherapy, surgery)
  • Female
  • Follow-Up Studies
  • Hemangiosarcoma (etiology, pathology)
  • Humans
  • Mastectomy, Segmental (methods)
  • Middle Aged
  • Neoplasms, Radiation-Induced (pathology)
  • Radiation Dosage
  • Radiotherapy, Adjuvant (adverse effects)
  • Risk Assessment
  • Skin Neoplasms (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: